期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 451, 期 4, 页码 615-621出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2014.08.035
关键词
MicroRNA; miR-21; Diabetic wound healing; TGF beta 1; NF kappa B
资金
- Ministry of Education, Culture, Sports, Science, and Technology, Japan
- Grants-in-Aid for Scientific Research [24592716] Funding Source: KAKEN
Transforming growth factor betal (TGF beta 1) is a pleiotropic growth factor with a very broad spectrum of effects on wound healing. Chronic non-healing wounds such as diabetic foot ulcers express reduced levels of TGF beta 1. On the other hand, our previous studies have shown that the microRNA miR-21 is differentially regulated in diabetic wounds and that it promotes migration of fibroblast cells. Although interplay between TGF beta 1 and miR-21 are studied in relation to cancer, their interaction in the context of chronic wounds has not yet been investigated. In this study, we examined if TGF beta 1 could stimulate miR-21 in fibroblasts that are subjected to high glucose environment. MiR-21 was, in fact, induced by TGF beta 1 in high glucose conditions. The induction by TGF beta 1 was dependent on NF kappa B activation and subsequent ROS generation. TGF beta 1 was instrumental in degrading the NF kappa B inhibitor I kappa B alpha and facilitating the nuclear translocation of NF kappa B p65 subunit. EMSA studies showed enhanced DNA binding activity of NF kappa B in the presence of TGF beta 1. ChIP assay revealed binding of p65 to miR-21 promoter. NF kappa B activation was also required for the nuclear translocation of Smad 4 protein and subsequent direct interaction of Smad proteins with primary miR-21 as revealed by RNA-IP studies. Our results show that manipulation of TGF beta 1-NF kappa B-miR-21 pathway could serve as an innovative approach towards therapeutics to heal diabetic ulcers. (C) 2014 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据